These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1277534)

  • 1. Suppression of craving and withdrawal in humans addicted to narcotics or amphetamines by administration of alpha-methyl-para-tyrosine (AMPT) and 5-butylpicolinic acid (fusaric acid) treatment of narcotic and amphetamine addiction in humans: preliminary report.
    Pozuels J
    Cleve Clin Q; 1976; 43(2):89-94. PubMed ID: 1277534
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of craving and other signs of dependence in morphine-addicted monkeys by administration of alpha-methyl-para-tyrosine.
    Pozuelo J; Kerr FW
    Mayo Clin Proc; 1972 Sep; 47(9):621-8. PubMed ID: 4262982
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of pheochromocytoma with fusaric acid].
    Shimpo S; Sakata K; Kawashimo K; Kanagi R; Omori Y
    Horumon To Rinsho; 1976 Jun; 24(6):571-6. PubMed ID: 986906
    [No Abstract]   [Full Text] [Related]  

  • 4. [Proceedings: Case of pheochromocytoma].
    Kawahara H; Kuzutani F; Mizuno S
    Jpn Circ J; 1975 Jul; 39(7):871. PubMed ID: 1160060
    [No Abstract]   [Full Text] [Related]  

  • 5. [Contribution to the biochemical treatment of the Parkinson's disease (author's transl)].
    Calatayud Maldonado V
    Rev Esp Otoneurooftalmol Neurocir; 1978; 36(204):33-41. PubMed ID: 741072
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of fusaric acid calcium on catecholamine metabolism and its clinical effects on essential hypertension].
    Ozawa M; Nakajima Y; Suzuki K; Sato T; Takahashi E
    Horumon To Rinsho; 1976 Jan; 24(1):79-86. PubMed ID: 942902
    [No Abstract]   [Full Text] [Related]  

  • 7. Delay of nomifensine-induced seizures by fusaric acid, alpha-methyltyrosine and haloperidol.
    Huff MR; Meadows GG; Johnson WE
    Res Commun Chem Pathol Pharmacol; 1986 Mar; 51(3):413-6. PubMed ID: 3704316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-arrhythmia activity of fusaric acid N,N-diethylaminoethylamide in experimental arrhythmia models in comparison with novocainamide].
    Savina MD; Kudrin AN
    Farmakol Toksikol; 1982; 45(2):63-5. PubMed ID: 7075754
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of narcotic withdrawal symptoms with thioridazine.
    Mulvaney RB
    Dis Nerv Syst; 1966 May; 27(5):329-30. PubMed ID: 5935215
    [No Abstract]   [Full Text] [Related]  

  • 10. The hypotensive effect of fusaric acid: the results of long-term administration of fusaric acid in elderly hypertensive patients.
    Terasawa F; Ying LH; Kameyama M
    Jpn Circ J; 1976 Sep; 40(9):1017-23. PubMed ID: 994313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term hemodynamic effect of fusaric acid in elderly hypertensive patients.
    Terasawa F; Ying LH; Suzuki T
    Jpn Circ J; 1976 Sep; 40(9):1025-31. PubMed ID: 994314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative effectiveness of the beta-(N,N-diethylamino)ethylamide hydrochloride of fusaric acid, obzidan and atenolol in experimental adrenaline-induced cardiac arrhythmia].
    Savina MD
    Farmakol Toksikol; 1986; 49(3):47-50. PubMed ID: 3720934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antihypertensive effect of trifluoropentoxypicolinic acid: a pharmacokinetic study].
    Horisaka K; Masuda S
    Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):301-7. PubMed ID: 6745810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral effects of a new dopamine-beta-hydroxylase inhibitor (fusaric acid) in man.
    Goodwin FK; Sack RL
    J Psychiatr Res; 1974; 11():211-7. PubMed ID: 4618285
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of fusaric acid (a dopamine beta-hydroxylase inhibitor) on phaeochromocytoma.
    Nagasaka A; Hara I; Imai Y; Uchikawa T; Yamauchi K; Suzuki S; Takatsuki K; Tomita A; Niinomi M; Nakagawa H
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):437-44. PubMed ID: 3987067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fusaric acid on tardive dyskinesia and mental state in psychogeriatric patients. A pilot study.
    Viukari M; Linnoila M
    Acta Psychiatr Scand; 1977 Jul; 56(1):57-61. PubMed ID: 331875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary norepinephrine excretion in elderly hypertensive patients during administration of fusaric acid.
    Terasawa F; Ying LH; Suzuki T; Hidaka H
    Jpn Circ J; 1976 Sep; 40(9):1033-7. PubMed ID: 994315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel blocking drugs in the management of drug dependence, withdrawal and craving. A clinical pilot study with nifedipine and verapamil.
    Shulman A; Jagoda J; Laycock G; Kelly H
    Aust Fam Physician; 1998 Jan; 27 Suppl 1():S19-24. PubMed ID: 9503731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bupropion for amphetamine withdrawal syndrome.
    Chan-Ob T; Kuntawongse N; Boonyanaruthee V
    J Med Assoc Thai; 2001 Dec; 84(12):1763-5. PubMed ID: 11999825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Carpipramine and drug addiction].
    Benyacoub A; Roux JM
    Encephale; 1978; 4(5 Suppl):596-600. PubMed ID: 380973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.